BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11324309)

  • 1. [Chemotherapy of colonic carcinoma in the year 2001].
    Mross K; Semsek D
    Praxis (Bern 1994); 2001 Mar; 90(12):497-510. PubMed ID: 11324309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
    Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and radiochemotherapy of colorectal cancers: adjuvant and palliative therapeutic procedures].
    Porschen R; Bermann A
    Leber Magen Darm; 1994 Jul; 24(4):164-9. PubMed ID: 7523820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of chemotherapy in cancers of the colon].
    Seitz JF; Rougier P
    Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
    J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
    Scheithauer W
    Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for colorectal carcinoma.
    Kim R; Yamaguchi Y; Toge T
    Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant therapy of colon carcinoma].
    Trarbach T; Kubicka S; Hacker U; Ridwelski K; Reinacher-Schick A
    Onkologie; 2008; 31 Suppl 5():19-23. PubMed ID: 19033700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New adjuvant therapy for colon cancer: justified hope or commercial hype.
    Galanis E; Alberts SR; O'Connell MJ
    Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal treatment of colon cancer?].
    Fahlke J; Schmidt C; Tautenhahn J; Hribaschek A; Stübs P; Lippert H
    Zentralbl Chir; 2006 Apr; 131(2):126-33. PubMed ID: 16612779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.